Use of Spirometry Testing in the Assessment and Diagnosis of COPD (SPR)

Assesses adults 40 years of age and older who have a new diagnosis of chronic obstructive pulmonary disease (COPD) or newly active COPD, who received spirometry testing to confirm the diagnosis.

Why It Matters

COPD is a progressive, irreversible respiratory condition. It is the third leading cause of the death in the United States.1,2 Spirometry testing is recommended by the Global Initiative for Chronic Obstructive Lung Disease as the preferred method for diagnosing COPD.2 Despite being the gold standard for diagnosis and assessment of COPD, spirometry testing is underused. Earlier diagnosis using spirometry testing supports a treatment plan that may protect against worsening symptoms and decrease the number of exacerbations.

Results

SPIROMETRY TESTING RATE
CommercialMedicaidMedicare
YearHMOPPOHMOHMOPPO
201741.639.631.634.233.5
201642.040.531.634.935.0
201543.441.131.036.336.6
201443.041.231.036.335.0
201342.541.031.036.035.6
201243.541.531.536.835.0
201142.940.532.036.335.6
201041.740.231.333.935.3
200938.836.728.628.528.8
200837.636.429.327.726.5
200735.733.728.427.225.4
200636.133.727.326.230.2

References

  1. Hoyert, D., and J. Xu. 2012. “Deaths: Preliminary Data for 2011.” National Vital Statistics Reports 61(6):1-52. http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf
  2. Global Initiative for Chronic Obstructive Lung Disease. 2014. “Global Strategy for the Diagnosis, and Prevention of Chronic Obstructive Pulmonary Disease.”

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.